These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 7490121

  • 1. Peptides of a major histocompatibility complex class I (Kb) molecule cause prolongation of skin graft survival and induce specific down-regulatory T cells demonstrable in the mixed lymphocyte reaction.
    Brondz BD, Kazansky DB, Chernyshova AD, Ivanov VS.
    Immunology; 1995 Oct; 86(2):219-23. PubMed ID: 7490121
    [Abstract] [Full Text] [Related]

  • 2. [Use of peptides of major histocompatibility type I molecules for induction of specific T-suppressors in vivo in an allogeneic system and extending the life of a murine skin transplant].
    Brondz BD, Kazanskiĭ DB, Chernysheva AD, Ivanov VS, Ostrovskiĭ AG, Erokhin VP.
    Mol Biol (Mosk); 1994 Oct; 28(5):1113-20. PubMed ID: 7990835
    [Abstract] [Full Text] [Related]

  • 3. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
    Choksi S, Kim JC, Whitaker-Menezes D, Murphy GF, Friedman TM, Korngold R.
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
    [Abstract] [Full Text] [Related]

  • 4. [Use of histocompatibility class I molecule peptides for in vivo induction of specific T-suppressors in allogenic systems and prolongation of mouse skin graft life].
    Brondz BD, Kazanskiĭ DB, Chernysheva AD, Ivanov VS, Ostrovskiĭ AG, Erokhin VP.
    Vestn Ross Akad Med Nauk; 1995 Oct; (4):38-42. PubMed ID: 7780340
    [Abstract] [Full Text] [Related]

  • 5. The mechanism of specific prolongation of class I-mismatched skin grafts induced by retroviral gene therapy.
    Mayfield RS, Hayashi H, Sawada T, Bergen K, LeGuern C, Sykes M, Sachs DH, Iacomini J.
    Eur J Immunol; 1997 May; 27(5):1177-81. PubMed ID: 9174608
    [Abstract] [Full Text] [Related]

  • 6. Specific unresponsiveness to a retrovirally-transferred class I antigen is controlled through the helper pathway.
    Fraser CC, Sykes M, Lee RS, Sachs DH, LeGuern C.
    J Immunol; 1995 Feb 15; 154(4):1587-95. PubMed ID: 7836744
    [Abstract] [Full Text] [Related]

  • 7. A synthetic CD4-CDR3 peptide analog enhances skin allograft survival across a MHC class II barrier.
    Koch U, Choksi S, Marcucci L, Korngold R.
    J Immunol; 1998 Jul 01; 161(1):421-9. PubMed ID: 9647252
    [Abstract] [Full Text] [Related]

  • 8. Alloantigenic sites on class I major histocompatibility complex antigens: 61-69 region in the first domain of the H-2Kb molecule induces specific antibody and T cell responses.
    Singh B, Waters CA, Swanlund D.
    J Immunol; 1986 Oct 01; 137(7):2311-8. PubMed ID: 2428867
    [Abstract] [Full Text] [Related]

  • 9. Both L- and D-isomers of allotrap 2702 prolong cardiac allograft survival in mice.
    Gao L, Woo J, Buelow R.
    J Heart Lung Transplant; 1996 Jan 01; 15(1 Pt 1):78-87. PubMed ID: 8820086
    [Abstract] [Full Text] [Related]

  • 10. Functional differentiation in the genetic control of murine T lymphocyte responses to human fibrinopeptide B.
    Peterson LB, Wilner GD, Thomas DW.
    J Immunol; 1983 Feb 01; 130(2):637-43. PubMed ID: 6217245
    [Abstract] [Full Text] [Related]

  • 11. Mechanism of portal venous tolerant long-term MHC Class I L(d)-specific skin graft survival in transgenic 2CF1 mice.
    Margenthaler JA, Landeros K, Kataoka M, Flye MW.
    Transpl Immunol; 2003 Feb 01; 11(1):23-9. PubMed ID: 12727472
    [Abstract] [Full Text] [Related]

  • 12. High frequency of splenic anti-class I cytotoxic T lymphocyte precursors correlates with in vivo rejection of K/D region disparate thyroid and islet grafts in mice.
    Isakov N, Bach FH.
    J Immunol; 1984 Jan 01; 132(1):50-6. PubMed ID: 6418804
    [Abstract] [Full Text] [Related]

  • 13. Pretreatment of donor stimulator cells by 16,16 dimethyl prostaglandin E2 influences the recipient immune response.
    Chung SW, Gould B, Zhang R, Hu Y, Levy GA, Gorczynski RM.
    Surgery; 1998 Feb 01; 123(2):171-80. PubMed ID: 9481403
    [Abstract] [Full Text] [Related]

  • 14. Differential genetic requirements for in vivo and in vitro induction of T-killer and T-suppressor cells in the mutant H-2Kb system and the cross-reactivity of the T-killer clones.
    Brondz BD, Kahn ES, Chervonsky AV, Isakova VR, Apasov SG, Blandova ZK.
    Exp Clin Immunogenet; 1987 Feb 01; 4(4):211-21. PubMed ID: 2978841
    [Abstract] [Full Text] [Related]

  • 15. Host thymectomy and cyclosporine lead to unstable skin graft tolerance after class I mismatched allogeneic neonatal thymic transplantation in mice.
    Rodríguez-Barbosa JI, Haller GW, Zhao G, Sachs DH, Sykes M.
    Transpl Immunol; 2005 Oct 01; 15(1):25-33. PubMed ID: 16223670
    [Abstract] [Full Text] [Related]

  • 16. Microheterogeneity in regulatory circuits for T-cell alloresponsiveness.
    Gorczynski RM, Macrae S.
    Immunology; 1981 Dec 01; 44(4):827-46. PubMed ID: 6172375
    [Abstract] [Full Text] [Related]

  • 17. Recognition and response to alloantigens in vivo. I. Negative and positive selection of MLR reactivity in murine peripheral blood lymphocytes to major histocompatibility complex and Mls antigens.
    Ryan JJ, Ahmed A, Kind PD, Thompson CB, Berning AK, Sell KW.
    J Immunol; 1984 Aug 01; 133(2):606-15. PubMed ID: 6234352
    [Abstract] [Full Text] [Related]

  • 18. Tolerance induction to multiple minor histoincompatible cells by activated B cells is associated with preferential activation of Th2 cells.
    Gorczynski RM, Kiziroglu F.
    Transplantation; 1994 Jul 15; 58(1):51-8. PubMed ID: 8036708
    [Abstract] [Full Text] [Related]

  • 19. Survival of skin allografts is prolonged in mice with a dominant-negative H-Ras.
    Funeshima-Fuji N, Fujino M, Kimura H, Takahara S, Nakayama T, Ezaki T, Li XK.
    Transpl Immunol; 2008 Feb 15; 18(4):302-6. PubMed ID: 18158115
    [Abstract] [Full Text] [Related]

  • 20. Specific tolerance induction of allo-K(b)-skin grafts by FK506 in the CD8-depleted H-2(k) recipients required low amounts of K(b)-antigen.
    Chen BG, Liu Z, Wu Y.
    Transpl Immunol; 2005 Oct 15; 15(1):9-16. PubMed ID: 16223668
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.